The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Kane Biotech Inc closed at $0.04.

Over the last five days, shares have gained 14.29% and 14.29% year to date. Shares have underperformed the S&P TSX by 46.55% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated at previous session's close. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-2,411.28%

Although this company's net profit margin is negative, it is above the industry average and implies that Kane Biotech Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.30%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit000--
Total cost of revenue000--
Total operating expense0000
Selling / general / administrative0000
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income0000
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--000
Other--------
Income before tax000-1
Income after tax000-1
Income tax, total--000
Net income000-1
Total adjustments to net income--------
Net income before extra. items000-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items000-1
Inc. avail. to common incl. extra. items000-1
Diluted net income000-1
Dilution adjustment0------
Diluted weighted average shares107888281
Diluted EPS excluding extraordinary itemsvalue per share0.00-0.010.00-0.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.00-0.010.00-0.01